1. Sindrilaru, A., S. Seeliger, J. M. Ehrchen, T. Peters, K. Scharffetter-Kochanek, J. Roth, and C. Sunderkötter:
    “Site of blood vessels damage and relevance of interactions between CD18 and immune complexes in leukocytoclastic vasculitis (in CD18-deficient mice).”
    J. Invest. Dermatol. 127, 447-454 (2007).
  2. Wittkowski, H., A. Sturrock, M. van Zoelen, D. Viemann, T. van der Poll, J. R. Hoidal, J. Roth, and D. Foell:
    ”Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.”
    Crit. Care Med. 35, 1369-1375 (2007).
  3. Viemann, D., M. Schmidt, K. Tenbrock, S. Schmid, V. Müller, K. Klimmek, S. Ludwig, J. Roth, and M. Goebeler:
    ” The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kB and hypoxia-inducible factor-1a.”
    J. Immunol. 178, 3198–3207 (2007).
  4. Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B, Kerkhoff C:
    ”HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities.”
    J. Invest. Dermatol. 127, 2001-2011 (2007).
  5. Wittkowski, H., D. Foell, E. af Klint, L. De Rycke, F. De Keyser, M. Frosch, A.-K. Ulfgren, and J. Roth:
    “Effects of intra-articular steroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.”
    Ann. Rheum. Dis. 66,1020-1025 (2007).
  6. Ehrchen, J., L. Helming, G. Varga, B. Pasche, K. Loser, M. Gunzer, C. Sunderkötter, C. Sorg, J. Roth, and A. Lengeling:
    ”Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.”
    FASEB J.
  7. Ehrchen, J., L. Steinmüller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkötter, and J. Roth:
    ”Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes.”
    Blood 109, 1265-1274 (2007).
  8. Viemann, D., K. Barczyk, T. Vogl, U. Fischer, C. Sunderkötter, K. Schulze-Osthoff, and J. Roth:
    ”MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program.”
    Blood 109, 2453-2460 (2007).
  9. Foell, D., H. Wittkowski, T. Vogl, and J. Roth:
    ”S100 proteins expressed in phagocytes: a novel group of damage associated molecular pattern molecules.”
    J. Leukoc. Biol. 81, 28–37 (2007).
  10. Foell, D., H. Wittkowski, and J. Roth:
    “Mechanisms of Disease: a ‘DAMP’ view on inflammatory arthritis.”
    Nature Clin. Pract. Rheum. 3, 382-390 (2007).
  11. Kaiser, T., J. Langhorst, H. Wittkowski, K. Becker, A. W. Friedrich, A. Rueffer, G. J. Dobos, J. Roth, and D. Foell
    "Fecal S100A12 as non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome."
    Gut, 2007 Dec;56(12):1706-13.
  12. Wittkowski, H., K. Hirono, F. Ichida, T. Vogl, F. Ye, X. Yanlin, K. Saito, K. Uese, T. Miyawaki, D. Viemann, J. Roth, and D. Foell
    "Acute kawasaki disease is associated with reverse regulation of soluble receptor for advanced glycation end products (sRAGE) and its proinflammatory ligand S100A12."
    Arthritis Rheum.2007 Dec;56(12):4174-81.
  13. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. D. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth.
    "MRP8 and MRP14 are novel endogenous activators of toll-like receptor 4 promoting lethal endotoxin-induced shock."
    Nature Med 2007 Sep;13(9):1042-9.
  14. Müller, V., D. Viemann, M. Schmidt, N. Endres, S. Ludwig, M. Leverkus, J. Roth, and M. Goebeler
    "Candida albicans triggers activation of distinct signaling pathways to establish a proinflammatory gene expression program in primary human endothelial cells."
    J. Immunol. 2007 Dec 15;179(12):8435-45
  15. van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J.:
    "Myeloid related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis."
    Ann Rheum Dis. 2007 Nov 30
  16. Nacken W, Kerkhoff C.:
    "The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant."
    FEBS Lett. 2007 Oct 30;581(26):5127-30